Literature DB >> 61440

Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer.

R H Purcell, W T London, V J McAuliffe, A E Palmer, P M Kaplan, J L Gerin, J Wagner, H Popper, E Lvovsky, D C Wong, H B Levy.   

Abstract

Chimpanzees chronically infected with hepatitis-B virus showed transient changes in several markers of infection when treated with the interferon inducer polyriboinosinic-polyribocytidylic acid-poly-l-lysine carboxymethyl cellulose. Serum Dane-particle-associated D.N.A. polymerase, e antigen and hepatitis-B surface antigen, and intrahepatic hepatitis-B surface and core antigens diminished during treatment. Defective (D.N.A.-polymerase-negative) Dane particles increased in titre transiently during treatment; these may play a role in the modulation of hepatitis-B virus infection. Humoral immune responses in chronic hepatitis-B carrier chimps were unaffected. Interferon inducers (or exogenous interferon) may be useful for the treatment of chronic hepatitis-B virus infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61440     DOI: 10.1016/s0140-6736(76)90598-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

Review 1.  The chimpanzee model for hepatitis B virus infection.

Authors:  Stefan F Wieland
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 2.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

Review 3.  Host-virus interactions in hepatitis B virus infection.

Authors:  Luca G Guidotti; Masanori Isogawa; Francis V Chisari
Journal:  Curr Opin Immunol       Date:  2015-07-15       Impact factor: 7.486

Review 4.  The hepatitis B virus and its DNA polymerase: the prototype three-D virus.

Authors:  S Z Hirschman
Journal:  Mol Cell Biochem       Date:  1979-07-15       Impact factor: 3.396

Review 5.  Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.

Authors:  Aleksei Suslov; Stefan Wieland; Stephan Menne
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

6.  Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

Authors:  H McClary; R Koch; F V Chisari; L G Guidotti
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus.

Authors:  N Stebbing; I J Lindley; K M Dawson
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

Review 8.  Recent advances in the identification of hepatitis viruses.

Authors:  J L Dienstag; R H Purcell
Journal:  Postgrad Med J       Date:  1977-07       Impact factor: 2.401

9.  Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.

Authors:  D A Stringfellow; S D Weed
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

10.  Liver disease and the e antigen in HBsAg carriers with chronic renal failure.

Authors:  G P Coughlin; A G Van Deth; A P Disney; J Hay; A G Wangel
Journal:  Gut       Date:  1980-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.